HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia.

AbstractOBJECTIVE:
Reactive oxygen species (ROS) contribute to oxidative lung injury. The glutathione-S-transferases (GST) family and microsomal epoxide hydrolase (mEPHx) enzymes detoxify ROS, and genetic polymorphisms alter this detoxification. We hypothesized that polymorphisms encoding for less efficient enzymes were associated with bronchopulmonary dysphasia (BPD).
STUDY DESIGN:
We determined allelic distribution of these polymorphisms in a pilot study of 35 BPD cases and 98 controls. chi2 and regression analysis were performed.
RESULTS:
GST P1 val105ile distribution differed between the groups, with the more efficient val/val allele predominantly in controls (p< or =0.05). When controlling for race and sex, BPD cases were less likely to be homozygotes for the val/val isoform (OR 0.21, CI: 0.045-0.95, p=0.04) and more likely to possess the less efficient ile isoform (OR 4.5, CI: 1.0-20.7, p=0.05).
CONCLUSIONS:
This pilot study suggests that BPD is associated with the presence of the GST-P1 105ile allele. Future prospective studies are warranted.
AuthorsMartha H Manar, Milton R Brown, Theresa W Gauthier, Lou Ann S Brown
JournalJournal of perinatology : official journal of the California Perinatal Association (J Perinatol) Vol. 24 Issue 1 Pg. 30-5 (Jan 2004) ISSN: 0743-8346 [Print] United States
PMID14726935 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Glutathione Transferase
Topics
  • Bronchopulmonary Dysplasia (diagnosis, genetics)
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Glutathione Transferase (genetics)
  • Humans
  • Infant, Newborn
  • Male
  • Multivariate Analysis
  • Pilot Projects
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Probability
  • Reference Values
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: